ACT Machine

 The Activated Clotting Time (ACT) was first described by Hattersley in 1966 and is essentially a point of care test (POCT) of coagulation that is used to monitor the anticoagulant effect of unfractionated heparin (UFH) in patients on bypass surgery, on ECMO [extracorporeal membrane oxygenation,] undergoing percutaneous transluminal coronary angioplasty, on haemofiltration or haemodialysis.

The Activated Clotting Time Machine (ACT Machine) is used for managing anti-coagulation effects of Unfractioned Heparin. Advanced instrument like Sonoclot ACT Machine can also be used for monitoring effects of Low Molecular Weight Heparin (LMWH).  ACT Machine is used in Cath Lab, Cardiac Surgery, ECMO, Dialysis